Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: Frequency and differential penetrance in ovarian cancer and in breast- ovarian cancer families

American Journal of Human Genetics

Volumn 60, Issue 5, 1997, Pages 1059-1067

  Levy Lahad, Ephrat ^a   Catane, Raphael ^a   Eisenberg, Shlomit ^a   Kaufman, Bella ^a   Hornreich, Gila ^a   Lishinsky, Ella ^a   Shohat, Mordechai ^c   Weber, Barbara L ^d   Beller, Uziel ^a   Lahad, Amnon ^b   Halle, David ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; FAMILY HISTORY; FEMALE; GENE MUTATION; GERM LINE; HUMAN; ISRAEL; JEW; MAJOR CLINICAL STUDY; OVARY CANCER; PENETRANCE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BRCA2 PROTEIN; BREAST NEOPLASMS; EUROPE; FEMALE; FOUNDER EFFECT; GENE FREQUENCY; GENES, BRCA1; HETEROZYGOTE; HUMANS; IRAN; ISRAEL; JEWS; MALE; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PREVALENCE; TRANSCRIPTION FACTORS;

EID: 16944363862     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Butler LM, Schubert E, Oddoux C, Morrow J, Reich E, Hull JL, Ostrer H, et al (1996) Fifty percent of Jewish high-risk breast and ovarian cancer families are not explained by the three known BRCA1 and BRCA2 founder mutations while a 0.7% combined BRCA1 founder mutaton frequency is reported in a Jewish cohort. Am J Hum Genet Suppl 59: A28
2. Claus EB, Risch N, Thompson WD (1991) Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study. Am J Hum Genet 48:232-242
3. Couch FJ, Farid LM, DeShano ML, Tavtigian SV, Calzone K, Campeau L, Peng Y, et al (1996) BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet 13:123-125
4. Couch FJ, Weber BL, Breast Cancer Information Core (1996) Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Hum Mutat 8:8-18
5. Easton DF, Bishop DT, Ford D, Cockford GP, Breast Cancer Linkage Consortium (1993) Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 52:678-701
6. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE, Breast Cancer Linkage Consortium (1994) Risks of cancer in BRCA1-mutation carriers. Lancet 343:692-695
7. Friedman LS, Szabo CI, Ostermeyer EA, Dowd P, Butler L, Park T, Lee MK, et al (1995) Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. Am J Hum Genet 57:1284-1297
8. Ganguly, A, Rock MJ, Prockop DJ (1993) Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double stranded PCR products and DNA fragments: evidence for solvent induced bends in DNA heteroduplexes. Proc Natl Acad Sci USA 90:10325-10329
9. Gayther SA, Warren W, Mazoyer S, Russell PA, Harrington PA, Chiano M, Seal S, et al (1995) Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for genotype-phenotype correlation. Nat Genet 11:428-433
10. Harris JR, Lippman ME, Morrow M, Hellman S (eds) (1996) Diseases of the breast. Lippincott-Raven, New York
11. Johannesdottir G, Gudmundsson J, Bergthorsson JT, Arason A, Eiriksdottir G, Johannsson OT, Borg A, et al (1996) High prevalence of the 999del5 mutation in Icelandic breast and ovarian cancer patients. Cancer Res 56:3663-3665
12. Knapp RC, Berkowitz RS (eds) (1993) Gynecologic oncology, 2d ed. McGraw-Hill, New York
13. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71
14. Modan B, Gak E, Bar Sade-Bruchim R, Hirsch-Yechezkel G, Theodor L, Lubin F, Lubin F, et al (1996) High frequency og BRCA1 185delAG mutation in ovarian cancer in Israel. JAMA 276:1823-1825
15. Neuhausen S, Gilewski T, Norton L, Tran T, McGuire P, Swensen J, Hampel H, et al (1996) Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat Genet 13:126-128
16. Newell VA (1961) Distribution of cancer mortality among ethnic subgroups of the white population of New York City, 1953-58. J Natl Cancer Inst 26:405-417
17. Norusis MJ (ed) (1994) SPSS 6.1: guide to data analysis. Prentice-Hall, Englewood Cliffs, NJ
18. Novakovic B, Goldstein AM, Tucker MA (1996) Validation of family history of cancer in deceased family members. J Natl Cancer Inst 88:1492-1493
19. Oddoux C, Struewing JP, Clayton CM, Neuhausen S, Brody LC, Kaback M, Haas B, et al (1996) The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet 14:188-190
20. Offit K, Gilewski T, McGuire P, Schluger A, Hampel H, Brown K, Swensen J, et al (1996) Germline BRCA1 185delAG mutations in Jewish women with breast cancer. Lancet 347: 1643-1645
21. Roa BB, Boyd AA, Volcik K, Richards CS (1996) Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 14:185-187
22. Sher C, Sharabini-Gargir L, Shohat M (1996) Breast cancer and BRCA1 mutations. N Engl J Med 334:1199-1200
23. Simard J, Tonin P, Durocher F, Morgan K, Rommens J, Gingras S, Samson C, et al (1994) Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet 8:392-398
24. Steinitz R, Parkin DM, Young JL, Bieber CA, Katz L (eds) (1989) Cancer incidence in Jewish migrants to Israel 1961-1981. IARC Scientific Publication 98. International Agency for Research on Cancer, Lyon
25. Struewing JP, Abeliovich D, Peretz T, Avishai N, Kaback MM, Collins FS, Brody LC (1995) The carrier frequency of the BRCA 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 11:198-200
26. Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, Merajver S, et al (1996) The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 12:333-337
27. Tonin P, Weber B, Offit K, Couch F, Rebbeck TR, Neuhausen S, Godwin AK, et al (1996) Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med 2:1179-1183
28. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, et al (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792
29. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265:2088-2090